Quick Takeaways
- Galaxy Group Funding ECI U LLC filed SCHEDULE 13G/A for ATAI Life Sciences N.V. Common Shares (ATAI).
- Disclosed ownership: 4.2%.
- Date of event: 31 Mar 2025.
Galaxy Group Funding ECI U LLC - 31 Mar 2025 SCHEDULE 13G/A Report for ATAI Life Sciences N.V. Common Shares (ATAI)
- Filing Manager
- Galaxy Group Funding ECI U LLC
- Reporting Manager
- Galaxy Group Funding ECI U LLC
- Symbol
- ATAI
- Shares outstanding
- 201,708,000 shares
- Disclosed Ownership
- 8,471,736 shares
- Ownership
- 4.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 27 May 2025, 16:14:55 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Galaxy Group Funding ECI U LLC disclosed 4.2% ownership in ATAI Life Sciences N.V. Common Shares (ATAI) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 27 May 2025, 16:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Galaxy Group Funding ECI U LLC | 4.2% | 8,471,736 | 0 | 8,471,736 | /s/ Nicholas Holderness | Nicholas Holderness, Chief Operating Officer | |
| Galaxy Group Investments LLC | 4.2% | 8,471,736 | 0 | 8,471,736 | /s/ Nicholas Holderness | Nicholas Holderness, Chief Operating Officer | |
| Michael E. Novogratz | 4.2% | 8,471,736 | 0 | 8,471,736 | /s/ Michael E. Novogratz | Michael E. Novogratz |